We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.43%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.22B
AUM Growth
-$35.2M
(-2.8%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-5.77%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
235
New
29
Increased
65
Reduced
100
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$12.6M |
| 2 |
Citigroup
C
|
+$12M |
| 3 |
Aptiv
APTV
|
+$10.5M |
| 4 |
Intel
INTC
|
+$8.69M |
| 5 |
ESND
Essendant Inc.
ESND
|
+$6.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$15M |
| 2 |
Leidos
LDOS
|
+$12.7M |
| 3 |
Kimberly-Clark
KMB
|
+$9.8M |
| 4 |
Bank of America
BAC
|
+$7.05M |
| 5 |
ITT
ITT
|
+$6.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Financials | 17.78% |
| 3 | Healthcare | 13.29% |
| 4 | Consumer Staples | 12.04% |
| 5 | Communication Services | 11.55% |
Similar funds
CBA
BC
KCM
KC
EWS
SCM
NI
QC
Philadelphia Trust Company's Q1 2017 Portfolio in Review
As of Q1 2017, Philadelphia Trust Company held 235 positions worth $1.22B, down 2.8% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Philadelphia Trust Company withdrew a net $70.2M in Q1 2017, closing 20 positions and reducing 100 holdings. Its most notable exit was Kimberly-Clark, an estimated $9.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Philadelphia Trust Company opened a new position in Aptiv worth $11.2M.
- Philadelphia Trust Company's largest Q1 2017 buy was Aptiv: 139,640 shares worth $11.2M.
- Philadelphia Trust Company added most to Qualcomm in Q1 2017, an estimated $12.6M increase.
- Philadelphia Trust Company's biggest Q1 2017 reduction was Quest Diagnostics, cutting an estimated $15M.
- Philadelphia Trust Company fully exited Kimberly-Clark in Q1 2017, selling an estimated $9.8M.
- Philadelphia Trust Company's ten largest holdings make up 26% of its $1.22B portfolio in Q1 2017.
- Philadelphia Trust Company opened 29 new positions and closed 20 in Q1 2017.
- Philadelphia Trust Company's portfolio value fell 2.8% quarter-over-quarter to $1.22B.
Based on Philadelphia Trust Company's 13F filing for Q1 2017, filed 15 May 2017.